Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitis

Inclusion Criteria: * Patients who have been in symptomatic remission from Ulcerative Colitis for at least 3 months. This is defined as a Partial Mayo Index Score of 0 or 1 * Age 18 years and above * Male or female * Patients who are able and willing to follow the treatment given and record responses in survey form Exclusion Criteria: * Patients who are currently experiencing symptomatic flares of mild or moderate ulcerative colitis, or have a partial mayo index score of 2 or greater * Patients who have been taking azathioprine or mercaptopurine for \<12 weeks for the treatment of their ulcerative colitis * Patients who are taking steroids, immunosuppressants, or biologic agents for the treatment of their ulcerative colitis * Patients who have severe ulcerative colitis * Patients who are noncompliant with medication or regular follow up visits * Patients who are unable or unwilling to record their responses in survey form * Patients with comorbid illnesses, including: Diabetes Mellitus, Stage III or above Congestive Heart Failure, chronic pancreatitis, severe liver or renal disease * Patients who have current gallstones or biliary dysfunction * Patients with anemia (Hemoglobin \<10), thrombocytopenia, abnormal lymphocyte counts, or coagulation abnormalities * Patients with current sepsis or current ongoing infection, including C. difficile colitis or enteritis * Patients with a history of malignancy * Patients who are currently pregnant or nursing * Patients who are current smokers